Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

BBH
VanEck Vectors Biotech ETF

  • Fund Description

    VanEck Vectors Biotech ETF (BBH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index (MVBBHTR), which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment.

  •  
      

    • Fund Ticker

      BBH
    • Exchange

      NASDAQ
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVBBHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 05/23/17

    • 30-Day SEC Yield1

      0.45%
    • Total Net Assets

      $659.8M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.40%
    • Net Expense Ratio/TER2

      0.35%
    • Distribution Frequency

      Annual
    • Next Distribution Date

      12/15/2017
  • Portfolio Composition (%)
    as of 05/23/17

    • % of Net Assets
    • Stocks

      99.92
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      0.08
  • Daily HoldingsDaily Holdings (%) as of 05/23/17

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Amgen Inc
    AMGN US
    506,311
    78,007,33611.82
    Celgene Corp
    CELG US
    612,264
    71,824,69010.89
    Gilead Sciences Inc
    GILD US
    1,016,845
    65,779,7039.97
    Allergan Plc
    AGN US
    239,564
    52,862,1928.01
    Vertex Pharmaceuticals Inc
    VRTX US
    331,581
    38,659,0295.86
    Biogen Inc
    BIIB US
    154,327
    38,288,5295.80
    Regeneron Pharmaceuticals Inc
    REGN US
    79,993
    36,906,3705.59
    Illumina Inc
    ILMN US
    185,566
    32,422,0924.91
    Quintiles Ims Holdings Inc
    Q US
    385,530
    32,307,4144.90
    Incyte Corp
    INCY US
    224,315
    30,542,7304.63
    Biomarin Pharmaceutical Inc
    BMRN US
    326,940
    28,888,4184.38
    Alexion Pharmaceuticals Inc
    ALXN US
    239,439
    25,054,8973.80
    Qiagen Nv
    QGEN US
    530,328
    17,368,2422.63
    Grifols Sa
    GRFS US
    699,021
    14,973,0302.27
    Tesaro Inc
    TSRO US
    78,690
    12,210,3271.85
    Charles River Laboratories Internationa
    CRL US
    128,214
    11,618,7531.76
    United Therapeutics Corp
    UTHR US
    90,901
    11,040,8351.67
    Alkermes Plc
    ALKS US
    189,025
    10,908,6331.65
    Ionis Pharmaceuticals Inc
    IONS US
    221,941
    10,018,4171.52
    Seattle Genetics Inc
    SGEN US
    148,687
    9,912,9621.50
    Neurocrine Biosciences Inc
    NBIX US
    173,280
    9,275,6781.41
    Alnylam Pharmaceuticals Inc
    ALNY US
    100,973
    7,559,8491.15
    Acadia Pharmaceuticals Inc
    ACAD US
    209,822
    5,780,5960.88
    Bluebird Bio Inc
    BLUE US
    53,275
    4,280,6460.65
    Intercept Pharmaceuticals Inc
    ICPT US
    25,102
    2,836,2750.43
    Other/Cash
    --
    --
    514,3810.08
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.